New lupane bidesmosides exhibiting strong cytotoxic activities in vitro
Language English Country United States Media print-electronic
Document type Journal Article, Research Support, Non-U.S. Gov't
PubMed
32388425
DOI
10.1016/j.bioorg.2020.103868
PII: S0045-2068(20)30191-7
Knihovny.cz E-resources
- Keywords
- Betulin bidesmosides, Birch bark, Cytotoxic activity, Structure–activity relationship, Synthesis,
- MeSH
- Cell Line MeSH
- HeLa Cells MeSH
- Humans MeSH
- MCF-7 Cells MeSH
- Neoplasms drug therapy MeSH
- Antineoplastic Agents chemical synthesis chemistry pharmacology MeSH
- Rhamnose analogs & derivatives chemical synthesis pharmacology MeSH
- Triterpenes chemical synthesis chemistry pharmacology MeSH
- Cell Survival drug effects MeSH
- Structure-Activity Relationship MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Names of Substances
- lupane MeSH Browser
- Antineoplastic Agents MeSH
- Rhamnose MeSH
- Triterpenes MeSH
Triterpene bidesmosides are considered as highly cytotoxic saponins, usually less toxic against normal cells than monodesmosides, and less haemolytic. Biological activity of the betulin-type bidesmosides, rarely found in Nature, and seldom prepared due to serious synthetic problems, is poorly recognized. We report herein a protocol for the preparation of disubstituted lupane saponins (betulin bidesmosides) by treatment of their benzoates with potassium carbonate in dichloromethane / methanol solution. Cytotoxicity of all compounds was tested in vitro for a series of cancer cell lines, as well as normal human skin BJ fibroblasts. Presence of l-rhamnose moiety is crucial for cytotoxicity of betulin bidesmosides. On the other hand, l-arabinose fragment connected to lupane C-3 carbon atom significantly decreases activity. Presented results clearly show that betulin bidesmosides have significant clinical potential as anticancer agents.
References provided by Crossref.org